Status:
UNKNOWN
Safety and Efficacy of Propofol Only Sedation in Oral and Maxillofacial Surgery
Lead Sponsor:
Atlantic Center for Oral and Maxillofacial Surgery
Conditions:
Procedural Sedation
Propofol
Eligibility:
All Genders
15-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if the use of propofol only to achieve procedural sedation for the removal of third molars is both safe and effective.
Detailed Description
Removal of third molars is a common procedure performed in North America. Many surgeon choose to complete the procedure using procedural sedation. The most commonly used combination of medications to ...
Eligibility Criteria
Inclusion
- ASA Class I and II patients between the ages of 16 to 50 years scheduled to have their third molars extracted under intravenous sedation.
Exclusion
- history of psychiatric illness, chronic use of central nervous system depressants or antidepressants, or alcohol abuse, had an active infection with systemic symptoms, were morbidly obese, were pregnant, or had a positive history of anesthetic-related complications.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2013
Estimated Enrollment :
169 Patients enrolled
Trial Details
Trial ID
NCT01227174
Start Date
January 1 2011
End Date
January 1 2013
Last Update
October 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlantic Centre for Oral and Maxillofacial Surgery 1278 Tower Rd.
Halifax, Nova Scotia, Canada, B3H 2Y9